Cathelicidin, An Antimicrobial Peptide Produced By Macrophages, Promotes Colon Cancer By Activating The Wnt/Beta-Catenin Pathway

Dong Li,Wenfang Liu,Xuan Wang,Junlu Wu,Wenqiang Quan,Yiwen Yao,Robert Bals,Shurong Ji,Kaiyin Wu,Jia Guo,Haiying Wan
DOI: https://doi.org/10.18632/oncotarget.2845
2015-01-01
Oncotarget
Abstract:Here we found that levels of cathelicidin, an antimicrobial peptide, were increased in colon cancer tissues compared to noncancerous tissues. Importantly, cathelicidin was mainly expressed in immune cells. Contact with tumor cells caused macrophages to secrete cathelicidin. Neutralization of cathelicidin, in vivo, significantly reduced the engraftment of macrophages into colon tumors, as well as proliferation of tumor cells, resulting in an inhibition of tumor growth. Furthermore, treatment with cathelicidin neutralizing antibody de-activated the Wnt/beta-catenin signaling pathway in tumor cells both in vivo and in vitro. Cathelicidin activated Wnt/beta-catenin signaling by inducing phosphorylation of PTEN, leading to activation of PI3K/Akt signaling and subsequent phosphorylation of GSK3 beta, resulting in stabilization and nuclear translocation of beta-catenin. These data indicate that cathelicidin, expressed by immune cells in the tumor microenvironment, promotes colon cancer growth through activation of the PTEN/PI3K/Akt and Wnt/beta-catenin signaling pathways.
What problem does this paper attempt to address?